| Application no. and date | 01994315.8 (espacenet) (Federated) (European Patent Register), 20011219 | | Patent/reg. no. and date | DK/EP 1343782, 20090506 | | Publication date | 20030917 | | Priority no. and date | US 257526 P, 20001221, US 262403 P, 20010116 | | EP pub. no. and date |
EP 1343782 20030917 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 152980 | | Inventor | BOLOOR, Amogh, 2302 17th Street, 10
Lubbock, TX 79401, US,
CHEUNG, Mui
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
DAVIS, Ronda
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
HARRIS, Philip, Anthony
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
HINKLE, Kevin
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
MOOK, Robert, Anthony,Jr.
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
STAFFORD, Jeffery, Alan
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US,
VEAL, James, Martin
GlaxoSmithKline, Five Moore Drive
PO Box 13398
Research Triangle Park, NC 27709, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 31/53 (2006.01) , A61P 35/00 (2006.01) , C07D 403/12 (2006.01) | | Title | Pyrimidinaminer som angiogenesemodulatorer | | Int. application no. | US2001049367 | | Int. publication no. | WO2002059110 | | Related patent (certificate) | CA 2010 00024 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
